2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈
2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈
2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 性质
| 沸点 | 632.8±55.0 °C(Predicted) |
|---|---|
| 密度 | 1.49±0.1 g/cm3(Predicted) |
| 储存条件 | Keep in dark place,Inert atmosphere,Room temperature |
| 溶解度 | 二甲基亚砜：16.67 mg/ml（39.26 mM） |
| 酸度系数(pKa) | -1.42±0.37(Predicted) |
| 形态 | 缓冲水溶液 |
| 颜色 | 米白色至灰色 |
2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 用途与合成方法
| Target | Value |
|
FOXM1
() | |
|
IL-13
() | |
|
STAT6
() | |
|
β-catenin
() |
RCM-1 blocks the nuclear localization and increased the proteasomal degradation of FOXM1, a transcription factor critical for the differentiation of goblet cells from airway progenitor cells. In cultured airway epithelial cells, RCM-1 reduces IL-13 and STAT6 signaling and prevented the expression of the STAT6 target genes Spdef and Foxa3, which are key transcriptional regulators of goblet cell differentiation.
RCM-1 reduces airway resistance, increased lung compliance, and decreased proinflammatory cytokine production in mice exposed to the house dust mite and interleukin-13 (IL-13), which triggers goblet cell metaplasia. In mice, RCM-1 reduces IL-13 and STAT6 signaling and prevented the expression of the STAT6 target genes Spdef and Foxa3.
2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-11-08 | HY-19979 | 2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 | 339163-65-4 | 5mg | 1500 |
| 2024-11-08 | HY-19979 | 2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 | 339163-65-4 | 10mM * 1mLin DMSO | 1650 |
